Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
A Dose-ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with PAH (BARD Study Phase 2)
Trial ID or NCT#
NCT02036970
Status
NOT RECRUITING
Purpose
This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 16 weeks of study participation.
Investigator(s)
Roham Zamanian, MD
Contact us to find out if this trial is right for you.
CONTACT
Val Scott
(650) 725-9861
View on ClinicalTrials.gov
About this Clinical Trial
Your Message Will Go To
Val Scott650-725-9861